ViiV Healthcare Gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe
Go back to ViiV Healthcare Gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.40 +1.38 (2.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.02 | 52 Week High | $45.58 | |||
| Open | $50.29 | 52 Week Low | $37.82 | |||
| Day High | $51.44 | P/E | N/A | |||
| Day Low | $49.97 | EPS | $0.00 | |||
| Volume | 3,220,701 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.40 +1.38 (2.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.02 | 52 Week High | $45.58 | |||
| Open | $50.29 | 52 Week Low | $37.82 | |||
| Day High | $51.44 | P/E | N/A | |||
| Day Low | $49.97 | EPS | $0.00 | |||
| Volume | 3,220,701 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.41 +0.56 (1.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.85 | 52 Week High | $37.39 | |||
| Open | $30.05 | 52 Week Low | $28.25 | |||
| Day High | $30.42 | P/E | 18.43 | |||
| Day Low | $29.88 | EPS | $1.65 | |||
| Volume | 18,492,988 | |||||



